These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Study of the psychoenergizing effects of a new derivative of dimethylaminoethanol]. Ey H; Bohard F; Le Borgne Y; Masanès P Evol Psychiatr (Paris); 1967; 32(3):703-8. PubMed ID: 5602490 [No Abstract] [Full Text] [Related]
25. [An open study on the clinical efficacy of citicoline in patients with chronic cerebral vasculopathy]. Rossi M; Zanardi M Clin Ter; 1993 Feb; 142(2):141-4. PubMed ID: 8472528 [TBL] [Abstract][Full Text] [Related]
26. A therapeutic trial of Atromid in multiple sclerosis. Prineas J; Simpson CA; Newell DJ; Miller H Neurology; 1967 Dec; 17(12):1185-9. PubMed ID: 4862519 [No Abstract] [Full Text] [Related]
27. [On the therapeutic use of the nucleosides, cytidine and uridine, in some neurological diseases]. Monticone GF; Bergamasco B; Cognazzo A Minerva Med; 1966 Dec; 57(101):4348-52. PubMed ID: 5958226 [No Abstract] [Full Text] [Related]
28. [The effect of longterm anticoagulant therapy after cerebrovascular accidents]. Matthys H Arch Klin Med; 1968; 214(2):120-34. PubMed ID: 5718734 [No Abstract] [Full Text] [Related]
29. [Neurology]. Carrera E; Bogousslavsky J Rev Med Suisse; 2005 Jan; 1(1):44-50. PubMed ID: 15773198 [TBL] [Abstract][Full Text] [Related]
30. A preliminary study of the effects of cyclandelate. Davies G Med J Aust; 1971 Feb; 1(6):313-7. PubMed ID: 4925923 [No Abstract] [Full Text] [Related]
31. Amantadine-induced livedo reticularis: a report of two cases. Hayes BB; Cook-Norris RH; Miller JL; Rodriguez A; Zic JA J Drugs Dermatol; 2006 Mar; 5(3):288-9. PubMed ID: 16573266 [TBL] [Abstract][Full Text] [Related]
33. [Neurology]. Botez S; Carota A; Dunand M; Du Pasquier R; Kuntzer T; Michel P; Morier J; Schluep M; Rossetti AO Rev Med Suisse; 2007 Jan; 3(93):39-47. PubMed ID: 17354660 [TBL] [Abstract][Full Text] [Related]
34. [On the relationship between the clinical picture of atherosclerotic Parkinsonism and age]. Oleĭnik LI Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(3):358-62. PubMed ID: 5795720 [No Abstract] [Full Text] [Related]
35. Advances in therapeutic neurology. Turner C Practitioner; 2001 Jun; 245(1623):551-5. PubMed ID: 11436265 [No Abstract] [Full Text] [Related]
36. Tizanidine treatment of spasticity: a meta-analysis of controlled, double-blind, comparative studies with baclofen and diazepam. Groves L; Shellenberger MK; Davis CS Adv Ther; 1998; 15(4):241-51. PubMed ID: 10186943 [TBL] [Abstract][Full Text] [Related]
37. [Clinical study of delayed onset of multiple sclerosis]. Giovannucci M G Psichiatr Neuropatol; 1968; 96(4):751-78. PubMed ID: 5738035 [No Abstract] [Full Text] [Related]
38. Randomized, double-blind study of pramipexole with placebo and bromocriptine in advanced Parkinson's disease. Mizuno Y; Yanagisawa N; Kuno S; Yamamoto M; Hasegawa K; Origasa H; Kowa H; Mov Disord; 2003 Oct; 18(10):1149-56. PubMed ID: 14534919 [TBL] [Abstract][Full Text] [Related]
39. [Results of laryngologic examinations and their relations to neurology]. Jeschek J Monatsschr Ohrenheilkd Laryngorhinol; 1967; 101(8):378-94. PubMed ID: 5627494 [No Abstract] [Full Text] [Related]
40. [Remote results of leukeran treatment of multiple sclerosis based on systematic clinical and paraclinical follow-up]. Olszewska Z; Arkuszewska C Reumatologia; 1981; 19(1):43-51. PubMed ID: 7291755 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]